No. | Gender | Age | Pathological diagnosis | Location | Pre-seed implant therapy | PS:NRS | ASIA | Ambulatory function score |
---|---|---|---|---|---|---|---|---|
1 | Male | 59 | Chordoma | S3 | S+RT60Gy | 5-6 | E | Â |
2 | Male | 69 | Chondrosarcoma | T9-11 | S | 4 | B | Â |
3 | Male | 50 | Chondrosarcoma | L2-S1 | S+RT60Gy | 8-9 | C | Â |
4 | Male | 50 | Parganglioma | L1-L2 | S+RT46Gy | 4-6 | C | Â |
5 | Male | 71 | Chondrosarcoma | C2-5 | S | 3 | D | Â |
6 | Male | 45 | Chondrosarcoma | L3,4 | S+RT64Gy+CTx | 4-5 | D | Â |
7 | Female | 20 | Lymphoma | S1-5 | CTx+RT54Gy | 6 | C | Â |
8 | Male | 46 | Osteosarcoma | S1-5 | CTx+RT54Gy | 4 | E | Â |
9 | Female | 57 | Fibromatosis | C3-T2 | RT60Gy | 3 | E | Â |
10 | Male | 47 | Chondrosarcoma | C4-T3 | S+RT64Gy | 3-4 | D | Â |
11 | Male | 69 | Chordoma | S3 | S+RT50Gy | 4 | E | Â |
12 | Male | 52 | Chordoma | C2-4 | S+RT44Gy | 1 | D | Â |
13 | Female | 57 | Chordoma | C2 | S+RT40Gy | 2 | D | Â |
14 | Female | 46 | Fibromatosis | T1-3 | S+RT78Gy | 2 | D | Â |
15 | Female | 68 | Malignant giant cell tumor | T1 | S+RT39.6Gy | 6 | C | Â |
16 | Male | 56 | Fibromatosis | C5 | S+RT50Gy | 4 | C | Â |
17 | Male | 52 | Malignant vertebral hemangioma | C2 | S+RT40Gy+CTx | 5-7 | C | Â |